Zobrazeno 1 - 10
of 31
pro vyhledávání: '"William C. Howland"'
Autor:
Jaeyune Ryu, Yogesh Surendranath, Corey J. Kaminsky, Ryan P. Bisbey, William C. Howland, Daniel T. Bregante
Publikováno v:
Nature Catalysis. 4:742-752
Heterogeneous aqueous-phase aerobic oxidations are important catalytic transformations; however, their mechanisms and the role of O2 remain unclear. Here we show that thermochemical aerobic oxidations of organic small molecules can be analysed as two
Publikováno v:
Journal of the American Chemical Society. 144(25)
Molecular metal complexes catalyze aerobic oxidation reactions via redox cycling at the metal center to effect sequential activation of O
Autor:
Sean F. McWilliams, Noémie Elgrishi, Jillian L. Dempsey, Daniel A. Kurtz, Chun-Hsing Chen, Banu Kandemir, William C. Howland, Debanjan Dhar
Publikováno v:
Journal of the American Chemical Society. 143(9)
Two-electron, one-proton reactions of a family of [CoCp(dxpe)(NCCH3)]2+ complexes (Cp = cyclopentadienyl, dxpe = 1,2-bis(di(aryl/alkyl)phosphino)ethane) form the corresponding hydride species [HCoCp(dxpe)]+ (dxpe = dppe (1,2-bis(diphenylphosphino)eth
Autor:
William C. Howland, Yogesh Surendranath, Daniel T. Bregante, Corey J. Kaminsky, Ryan P. Bisbey, Jaeyune Ryu
Heterogeneous aqueous-phase aerobic oxidations are an important emerging class of catalytic transformations, particularly for upgrading next generation bio-derived substrates. The mechanism of these reactions and the precise role of O2 in particular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22bf2e0a1b375e9d27d65c55c5ce3c04
https://doi.org/10.26434/chemrxiv.13830920
https://doi.org/10.26434/chemrxiv.13830920
Autor:
Julius van Bavel, Paul H. Ratner, Robert L. Jacobs, Ritu Karwal, William C. Howland, Frank C. Hampel, Dale Mohar
Publikováno v:
Annals of Allergy, Asthma & Immunology. 114:141-147
Background Allergic rhinitis (AR) is an inflammatory condition of the nasal mucosa characterized by symptoms of nasal discharge, itching, sneezing, and congestion. Ocular symptoms are commonly associated with AR and include itching or burning, tearin
Publikováno v:
The journal of physical chemistry. B. 120(32)
The proton-coupled electron transfer (PCET) oxidation of p-aminophenol in acetonitrile was initiated via stopped-flow rapid-mixing and spectroscopically monitored. For oxidation by ferrocenium in the presence of 7-(dimethylamino)quinoline proton acce
Autor:
Fred Bode, Bruce G. Martin, Paul H. Ratner, S.Y. Desai, Charles P. Andrews, William C. Howland, Joseph Hinkle, Holly Huang
Publikováno v:
Allergy and Asthma Proceedings. 33:27-35
A nasal aerosol formulation of ciclesonide with a hydrofluoroalkane propellant (CIC-HFA) is currently in development for treatment of allergic rhinitis (AR). This study evaluated the efficacy and safety of once-daily administration of CIC-HFA 74 or 1
Publikováno v:
International Forum of Allergy & Rhinology. 1:275-279
Background A previous study with azelastine nasal spray in patients with seasonal allergic rhinitis (SAR) demonstrated that increasing the azelastine concentration from 0.1% to 0.15% allowed for once-daily dosing without increasing the incidence of a
Publikováno v:
Annals of Allergy, Asthma & Immunology. 85:106-110
Background The proportion of older adults in the US population will increase dramatically in the near future, yet the frequency and nature of care furnished to older adults by Allergy/Immunology practitioners has not been described. Objective To dete
Autor:
William W. Storms, Jay Grossman, Reza Ehtessabian, Paul Chervinsky, Paul Ratner, Harold B. Kaiser, Guy A. Settipane, T. C. Sim, Dockhorn Rj, William C. Howland, Robert Webb, Kristin Drda, Edwin A Bronsky, Chester C. Wood, David S. Pearlman, Albert Finn, Donald W. Aaronson, Robert M. Cohen, James L. Sublett
Publikováno v:
Scopus-Elsevier
Background Perennial rhinitis is a common condition that affects up to 10% to 20% of the population. Multiple agents are frequently administered since no single agent provides complete relief. Studies assessing the benefit/risk of combined therapy ar